Back to dashboard
CommercialCoverageMedium impact

Policy Criteria Change

Arkansas Blue Cross Blue Shield·AR · Urology, Oncology, Endocrinology +1 more·Medical Policy
Effective date
Jan 15, 2026
We identified it
Jun 19, 2026
Days to comply

Summary

Arkansas Blue Cross updated coverage criteria for three procedures effective January 15, 2026. Cryoablation and radiofrequency ablation of renal tumors now have stricter size requirements (≤3.0 cm or 3.0-4.0 cm with specific conditions), and implantable continuous glucose monitoring devices now have coverage criteria for diabetes management in patients 18+ years old.

Action Required

Action needed
By January 15, 2026: Billing team must update prior authorization requirements and coverage criteria in billing system for renal tumor ablation procedures to reflect new size restrictions (≤3.0 cm or 3.0-4.0 cm with kidney function preservation needs or non-surgical candidates). Add age requirement (18+ years) for implantable CGM device coverage. Update encounter forms to remind providers that renal mass biopsy is required prior to or during ablation procedures. Claims not meeting new criteria will be denied.